Search

Introduction: Pilonidal disease is a common condition in adolescents and young adults that is managed with medications, local wound care and surgery. Immunosuppression is not a standard therapy utilized in this disease but is routinely prescribed in hidradenitis, a folliculitis in the axillae and groin rather than in the gluteal cleft. Case presentation: We present the case of a patient with severe pilonidal disease, with multiple collections in and above the gluteal cleft. Prior to presentation to our clinic, they had failed a standard treatment regimen for three years which included local wound care, multiple courses of antibiotics and incision and drainage procedures. They started on a treatment plan focused on hygiene and hair removal after being evaluated in our clinic. During this time, a concomitant diagnosis of leukemia was made and they were treated with induction chemotherapy and subsequent bone marrow transplant. Their pilonidal disease fully resolved after immunosuppression. Conclusion: This patient's severe pilonidal disease resolved with immunosuppression, supporting an inflammatory basis of the condition.

Summary: Background: Non-operative management for pediatric blunt splenic injury is well established in high-income countries, leading to a low splenectomy rate in hemodynamically stable children. Splenectomy rate became a quality indicator for Trauma Center verification utilized by the American College of Surgeons Committee on Trauma. However, data on splenectomy rate in children from countries with different income levels, such as Brazil, remain limited. This study aimed to assess the post-traumatic splenectomy rate among Brazilian children over the past decade and the relation with local resources. Methods: Data on pediatric splenic injuries and splenectomies from 2008 to 2019, including patient age and admitting service (adult or pediatric), were obtained from FioCruz database, a public, free, cloud-based platform that offers extensive national health data. The regional numbers of pediatric surgeons, pediatric intensive care unit (PICU) beds, and computed tomography scanners were obtained from Brazilian national databases. A national analysis of splenectomy rate by year and service of admission and an analysis of splenectomy rate by the level of regional resources, the number of pediatric surgeons, PICU beds, and computed tomography scanners was performed. Findings: 4061 children were hospitalized with a splenic injury, and 2287 (51.8%) of them underwent splenectomy, unchanged over time. 76.8% were male and 23.1% female patients with splenic injury. Mean age was 11.61 years old. The odds of splenectomy was 14.77 times higher for pediatric patients admitted under adult surgical service compared to pediatric service (OR = 14.77, 95% CI 11.75–18.56, p

Background: The impact of public health policy to reduce the spread of COVID-19 on access to surgical care is poorly defined. We aim to quantify the surgical backlog during the COVID-19 pandemic in the Brazilian public health system and determine the relationship between state-level policy response and the degree of state-level delays in public surgical care. Methods: Monthly estimates of surgical procedures performed per state from January 2016 to December 2020 were obtained from Brazil's Unified Health System Informatics Department. Forecasting models using historical surgical volume data before March 2020 (first reported COVID-19 case) were constructed to predict expected monthly operations from March through December 2020. Total, emergency, and elective surgical monthly backlogs were calculated by comparing reported volume to forecasted volume. Linear mixed effects models were used to model the relationship between public surgical delivery and two measures of health policy response: the COVID-19 Stringency Index (SI) and the Containment & Health Index (CHI) by state. Findings: Between March and December 2020, the total surgical backlog included 1,119,433 (95% Confidence Interval 762,663–1,523,995) total operations, 161,321 (95%CI 37,468–395,478) emergent operations, and 928,758 (95%CI 675,202–1,208,769) elective operations. Increased SI and CHI scores were associated with reductions in emergent surgical delays but increases in elective surgical backlogs. The maximum government stringency (score = 100) reduced emergency delays to nearly zero but tripled the elective surgical backlog. Interpretation: Strong health policy efforts to contain COVID-19 ensure minimal reductions in delivery of emergent surgery, but dramatically increase elective backlogs. Additional coordinated government efforts will be necessary to specifically address the increased elective backlogs that accompany stringent responses.

When a patient suffers a blunt intestinal injury after a low-energy mechanism, be prepared to find a pathologic area in the bowel. We present the case of a previously healthy 13-year-old female who presented complaining of abdominal pain hours after impact with the safety bar of an amusement park ride. Upon operative exploration, she was found to have extensive inflammation of the distal ileum including the ileocecal valve with creeping mesenteric fat and a full-thickness perforation of the inflamed segment. An ileocecectomy and primary anastomosis were performed. Pathology confirmed the presence of Crohn's disease. This case is the first reported incidence of a traumatic perforation leading to a diagnosis of pediatric Crohn's disease. Blunt perforation of the bowel following a low-impact mechanism should heighten the suspicion of an underlying disease process.

Immunotherapy has emerged as a promising strategy to eradicate cancer cells. Particularly, the development of cancer vaccines to induce a potent and sustained antigen-specific T cell response has become a center of attention. Herein, we describe a novel immunotherapy based on magnetic nanoparticles (MNP) covalently modified with the OVA254-267 antigen and a CpG oligonucleotide via disulfide bonds. The MNP-CpG-COVA significantly enhances dendritic cell activation and CD8+ T cell antitumoral response against B16-OVA melanoma cells in vitro. Notably, the immune response induced by the covalently modified MNP is more potent and sustained over time than that triggered by the free components, highlighting the advantage of nanoformulations in immunotherapies. What is more, the nanoparticles are stable in the blood after in vivo administration and induce potent levels of systemic tumor-specific effector CD8 + T cells. Overall, our findings highlight the potential of covalently functionalized MNP to induce robust immune responses against mouse melanoma.